Raphael Rousseau, See Remarks at Gritstone Oncology, Inc. (GRTS), sold 30,000 shares at $17.53 ($601K) on 2021-01-19, disclosed to the SEC on 2021-01-21.
Scheduled sale ($601k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.53 | 20,000 | $351K | 58.3% |
| 2 | $25.07 | 10,000 | $251K | 41.7% |
| Total | $20.04 avg | 30,000 | $601K | 100% |
| Filing → |